The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors

The enthusiasm for immune checkpoint inhibitors (ICIs), an efficient tumor treatment model different from traditional treatment, is based on their unprecedented antitumor effect, but the occurrence of immune-related adverse events (irAEs) is an obstacle to the prospect of ICI treatment. IrAEs are a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Exp Clin Cancer Res
Auteurs principaux: Jia, Xiao-Hui, Geng, Lu-Ying, Jiang, Pan-Pan, Xu, Hong, Nan, Ke-Jun, Yao, Yu, Jiang, Li-Li, Sun, Hong, Qin, Tian-Jie, Guo, Hui
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734811/
https://ncbi.nlm.nih.gov/pubmed/33317597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01749-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires